APYX Apyx Medical

Apyx Medical Corporation to Participate in Upcoming November Investor Conferences

Apyx Medical Corporation to Participate in Upcoming November Investor Conferences

CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conferences:

Event: 16th Annual Craig-Hallum Alpha Select Conference

Date: Tuesday, November 18, 2025

Location: Sheraton NY Times Square Hotel, New York, NY

Format: 1x1 Meetings

Event: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Date: Thursday, November 20, 2025

Location: Westin NY Grand Central, New York, NY

Format: 1x1 Meetings

To request a meeting with Apyx, investors should contact their Craig Hallum and Canaccord Genuity representatives.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and the AYON Body Contouring System™ in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System™ is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, tissue contraction, and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at 

Investor Relations Contact:

Jeremy Feffer

Managing Director

LifeSci Advisors

OP: 212-915-2568



EN
27/10/2025

Underlying

APYXApyx Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Apyx Medical

 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Announces Approval and Commercial Launch of A...

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in Sou...

December 3, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Announces Pricing of $10 Million Public Offer...

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the pricing of its previously announced underwritten public offering of 2,762,431 shares of its common stock at a public offering price of $3.62 per share of common stock, before deducting underwriting discounts and commissions and offering expenses. L...

November 18, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Announces Proposed Public Offering of Common ...

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size...

November 17, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation Reports Third Quarter 2025 Financial Results

Apyx Medical Corporation Reports Third Quarter 2025 Financial Results Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectationsSubmitted new 510(k) for AYON for device label expansion to include power liposuctionIncreased total revenue guidance for FY2025 to a range of $50.5 million to $52.5 millionManagement to host a conference call today at 8:00 a.m. ET CLEARWATER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical...

November 6, 2025 1 EN
 PRESS RELEASE
Free
APYX APYX MEDICAL

Apyx Medical Corporation to Participate in Upcoming November Investor ...

Apyx Medical Corporation to Participate in Upcoming November Investor Conferences CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conferences: Event: 16th Annual Craig-Hallum Alpha Select ConferenceDate: Tuesday, November 18, 2025Location: Sheraton NY Tim...

October 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch